Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
S H Kelkar is India's largest fragrance and flavor manufacturer, supplying essential oils, aroma chemicals, and finished fragrances to FMCG companies across personal care, home care, and food/beverage categories. The company operates manufacturing facilities in India, Indonesia, and Italy, serving both domestic Indian brands and multinational corporations with localized formulations. Stock performance is driven by raw material cost management (petrochemical derivatives, natural extracts), volume growth in Indian consumer markets, and margin expansion through backward integration.
SHK operates as a B2B supplier creating custom fragrance and flavor formulations for FMCG brands. Revenue is generated through long-term supply contracts with pricing tied to formulation complexity and volume commitments. Competitive advantages include deep customer relationships (co-development partnerships), extensive fragrance library (10,000+ formulations), and backward integration into aroma chemical production which provides 300-500 bps cost advantage versus competitors relying on third-party ingredients. Pricing power is moderate - contracts typically include pass-through clauses for raw material inflation but with 60-90 day lag, creating margin volatility.
Crude oil and petrochemical prices - 60-70% of raw materials are petroleum-derived aroma chemicals, with 90-day lag in contract price adjustments creating margin compression/expansion
Indian FMCG sector volume growth - particularly in mass-market personal care and home care categories where SHK has 35-40% market share
New customer wins and wallet share expansion with existing multinational clients (Unilever, P&G, Colgate)
Capacity utilization rates at Vapi and Mahad manufacturing facilities - operating leverage inflection above 75% utilization
Indonesian subsidiary performance - contributes 12-15% of revenue with higher margins due to proximity to palm oil derivatives
Synthetic biology disruption - fermentation-based aroma chemical production by companies like Ginkgo Bioworks and Amyris could reduce cost advantage of petrochemical-based ingredients by 30-40% over 5-7 years
Regulatory restrictions on certain aroma chemicals - EU REACH regulations and allergen labeling requirements forcing reformulation of legacy fragrances, creating R&D costs and potential customer churn
Sustainability pressures - increasing customer demand for natural/renewable ingredients versus petrochemical derivatives, requiring capex investment in bio-based feedstock capabilities
Global fragrance houses (Givaudan, Firmenich, IFF, Symrise) expanding India operations with superior R&D capabilities and broader ingredient portfolios - risk of losing multinational client business
Chinese aroma chemical producers (Zhejiang NHU, Wanxiang) offering 15-20% lower pricing on commodity ingredients, pressuring SHK's backward integration margins
Customer backward integration - large FMCG companies developing in-house fragrance capabilities for strategic products
Negative free cash flow of $0.8B driven by $1.0B capex (likely new manufacturing capacity or backward integration projects) creates near-term liquidity pressure - current ratio of 1.35 provides modest buffer
Working capital intensity - 150-180 days cash conversion cycle requires continuous access to revolving credit facilities; any disruption in banking relationships could constrain operations
Currency exposure - Indonesian subsidiary and Italian operations create EUR and IDR translation risk, though natural hedge exists as some raw materials imported in USD
moderate - Revenue correlates with Indian consumer spending on personal care and home care products, which grow 1.2-1.5x GDP in emerging middle-class demographics. However, fragrances represent only 2-4% of finished product cost for FMCG clients, making demand relatively inelastic during moderate slowdowns. Severe recessions (GDP contraction) impact premiumization trends and shift consumption toward value segments with lower fragrance content.
Moderate impact through two channels: (1) Working capital financing costs - company maintains 90-120 days of raw material inventory requiring revolving credit facilities, with 100 bps rate increase adding 30-40 bps to operating costs; (2) FMCG customer demand sensitivity - rising rates reduce discretionary spending on premium personal care products which carry higher fragrance loads and better margins for SHK. Valuation multiple contracts 1-2 turns with 100 bps rate increase as investors rotate from growth to value.
Moderate - Debt/Equity of 0.67 indicates manageable leverage, but negative free cash flow of $0.8B (likely due to capacity expansion capex) creates refinancing risk if credit markets tighten. FMCG customers have strong credit profiles minimizing receivables risk, but extended payment terms (60-75 days) require working capital financing. High yield credit spread widening above 500 bps would increase borrowing costs and potentially delay capacity expansion projects.
value - Stock trades at 1.0x Price/Sales and 8.7x EV/EBITDA, below global fragrance peers (Givaudan 4.5x P/S, IFF 2.8x P/S), attracting investors seeking India consumer exposure with margin expansion story. Recent 40% net income decline and negative FCF have created entry point for turnaround investors betting on capacity utilization recovery and raw material cost normalization. Not suitable for income investors (dividend yield likely minimal given negative FCF and growth capex needs).
high - Stock down 23% over six months reflecting earnings volatility from raw material cost pass-through lags and customer destocking cycles. Beta likely 1.3-1.5 given small-cap liquidity, emerging market exposure, and sensitivity to both crude oil prices and Indian consumer discretionary spending. Quarterly earnings can swing 300-500 bps in EBITDA margin based on petrochemical price movements and inventory revaluation.
